相关实验视频

Updated: Jan 16, 2026

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on: June 2, 2021

解读炎症性肠道疾病的分子景观:孟德尔的随机化和机器学习分析

Xuwen Zheng¹, Chenran Zhang¹, Muhammad Zubair^2,3

¹Emergency Department, Wujin Hospital Affiliated With Jiangsu University and Wujin Clinical College of Xuzhou Medical University, Changzhou, Jiangsu, China.

Journal of gastroenterology and hepatology

|October 1, 2025

概括

这项研究使用门德尔的随机化和机器学习来发现与炎症性肠病 (IBD) 相关的血蛋白. 几种蛋白质和基因被确定为IBD治疗的潜在治疗标.

科学领域:

遗传学遗传学是一个
代谢学代谢学代谢学
免疫学免疫学免疫学

背景情况:

炎症性肠病 (IBD) 是一个日益严重的全球健康挑战.
肠胃炎症的发病包括遗传,环境和代谢因素的复杂相互作用.
了解血蛋白关联对于IBD研究至关重要.

研究的目的:

研究血蛋白与IBD风险之间的因果关系.
确定IBD的新生物标志物和治疗点.
为了利用孟德尔的随机化和机器学习获得病因学的见解.

主要方法:

使用遗传变异作为仪器变量的双相门德尔随机化 (MR).
基于总结数据的MR和机器学习模型应用于大规模的遗传和蛋白质组数据.
在独立队列 (Pan-UKB,IIBDGC) 和SMR-Phenome-Wide协会研究 (SMR-PheWAS) 中进行验证.

主要成果:

几种血蛋白与IBD风险有显著的关联,在队列中得到证实.
机器学习确定了克罗恩病和性结肠炎预测的关键基因 (例如FCGR3A,MAPKAPK2).
潜在的治疗标包括GCKR,MSP和FCG2A,MSP和GCKR显示与其他疾病的因果关系.

结论:

这项研究使用先进的统计方法,为IBD病原体提供了新的见解.
鉴定出的蛋白质和基因为IBD的诊断和治疗提供了精准医学的潜力.
研究结果强调,需要在不同人群中进行验证,以扩大适用性.

关键词:

通过DNA甲基化.门德尔的随机化毒品目标是毒品的目标.炎症性肠病是一种炎症性肠病.机器学习是机器学习.

更多相关视频

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis

Published on: October 14, 2025

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...